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Immune deficiency induced by benzo(a)pyrene (BP) in
mice has been attributed to the metabolic intermediate
benzopyrene-7,8-dihydrodiol-9,10-epoxide (BPDE). Our
studies on mice progeny immune status after exposure of
the pregnant female at midgestation (11-12 days) show a
decided suppression in T-cell mediated immunity (CMI),
reflected by deficiencies, particularly in the T-cell
subsets L3T4 and Lyt 1. We hypothesize that this
condition could also be a result of covalent binding of
BPDE to DNA in T-lymphocytes (i.e., formation of BPDE-DNA
adducts), which affect their functional status. New
Zealand white rabbits were immunized with BPDE-DNA that
was synthesized in vitro and conjugated to a strong
immunogen, BSA, for the production of antibody against
BPDE-DNA, confirmed by ELISA. Immunoaffinity purified
anti-BPDE-DNA detected BPDE-DNA adducts in T-lymphocytes
by ELISA and flow cytometric analysis. Finally, adduct
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positive cells were determined to have
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INTRODUCTION
What do cigarettes, sunlight, solid "inert"
plastics, genetics, croton oil and benzopyrene-diol-
epoxide have in common? They are all said to be linked to
cancer. Carcinogenesis is a multistage process driven by
carcinogen induced genetic damage. Current theories of
chemical carcinogenesis recognize a sequence of events,
namely, initiation, promotion, and progression. These are
associated with a series of interrelated mechanisms,
including: metabolic oxygenation of the chemical,
particularly in conformationally hindered positions, to
form reactive intermediates, such as epoxides and other
ultimate carcinogens; and covalent binding of the
activated metabolite to nuclear DNA, resulting in possible
base changes and DNA rearrangements (Stevenson, 1990) .
Over 200 years have elapsed since the British surgeon
Sir Percival Pott made the observation that chimney sweeps
developed skin cancer because of their exposure to soot
(Pott, 1763) . This astute observation was the first
causal association between an environmental agent and
human cancer. By the 20th century, it has finally been
elucidated that the major carcinogenic constituent of coal
tar is benzopyrene because it exhibited the fluorescence
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property of the carcinogenic tars (Searl, 1984).
The carcinogenic activity of PAH's can be abolished,
diminished, or enhanced by metabolism through activation
or detoxification pathways. Differences in the activities
of these enzymes in individuals may be directly related to
individual susceptibility to carcinogenesis by the PAH's
(Gelboin, 1987). The affected cells may have decreased
responsiveness to the inter- and intracellular signals
that maintain normal tissue function and antigen
recognition (Harris, 1991) .
A prevalent class of potent environmental chemical
carcinogens is polycyclic aromatic hydrocarbons (PAH),
which are present in various petroleum and combustion
products from heat and power generation and motor vehicle
exhausts. Since PAH's are generally produced by pyrolysis
of organic matters such as in tobacco smoking and certain
procedures of food preparation, the PAH exposure of humans
is extensive (Gelboin, 1987). Benzopyrene-7,8-
dihydrodiol-9,10-epoxide (BPDE), often referred to as the
ultimate carcinogen of BP (Kapitulnik, 1978), is an
intermediate product of BP metabolism. BP is a ubiquitous
environmental pollutant found in industrial, commercial,
and domestic environments and in common household items
such as cigarette smoke, coal, etc. (Harris, 1985) . BP is
a compound with molecular formula CjqHi^Oj and M.W. 3 02.1.
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It is a crystalline solid which decomposes at 210°C and is
soluble in tetrahydrofuran and other organic solvents
(Harris, 1991).
PAH'S such as BP are metabolized by tissues to a
number of ring-substituted hydrogenated derivatives as
detoxification products. PAH's are activated by the mixed
function oxidases (epoxide hydrolase in the case of BP).
Pacifici et al.(1983) has reported on the presence of
nuclear epoxide hydrolase in human fetal liver and other
human tissues. The water-soluble products formed by
cells, although chemically uncharacterized, are likely to
be either sulfate, glutathione, or glucuronide conjugates
(Gelboin, 1980). The intermediate product, particularly
important is BPDE, adducts to DNA and other biological
macromolecules (Kapitulnik, 1978) . BP has also been shown
to induce high incidences of tumor (>80% in liver and
lung) in progeny when injected parenterally into the
pregnant mouse (Urso and Johnson, 1987). BP is also an
immunosuppressive agent when lymphoid tissues are exposed
in vitro (Harris, 1991; Urso, et al. 1986) . The objective
of this research is to determine if BPDE-DNA adducts can
be detected in immunocompromised lymphocytes and to
determine whether adduct presence renders these
lymphocytes more immunocompromised than non-adduct
containing lymphocytes.
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Adducts of BPDE-DNA have been detected in lymphocytes
and it is presumed that this contributes to the
immunosuppressive effect of BP, i.e. renders
immunocompetent cells deficient. Evidence for the
metabolic activation of a polycyclic aromatic hydrocarbon
to reactive intermediates was first reported in 1951 by
E.C. Miller. She applied BP to mouse skin and found
covalent binding of this hydrocarbon to skin protein. The
importance of DNA binding for the carcinogenicity of
polycyclic hydrocarbons on mouse skin was suggested in
1964 by Brookes and Lawley who found a correlation between
the carcinogenicity of several polycyclic hydrocarbons on
mouse skin and the covalent binding of these to mouse skin
DNA (Conney, 1982).
Two general types of mechanisms for chemical
carcinogenesis have been conceived. First, the carcinogen
may convert a normal cell into a tumor cell (instructional
theory), and second the carcinogen may modify the
environment of preexisting nascent neoplasm tumor cells so
that they are permitted to grow (selection theory)(Searle,
1984) .
The instructional theory encompasses several
mechanisms through which the carcinogen may effect a
heritable change within the cell. For example, the
carcinogen may cause a mutational change in the DNA of the
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cell, or may alter the control systems of the cell in a
way that leads to a heritable change. Similarly, the
selection theory accommodates mechanisms whereby the
carcinogen interferes with the immune response and thus
permits preexisting cancer cells to grow, or whereby the
carcinogen is simply toxic to normal cells and not to
preexisting cancer cells. However, both of these
mechanisms require that the carcinogen enter some cell of
the host and then interact with some cellular constituent.
These requisite conditions constitute the first step in
the complex process of chemical carcinogenesis (Searle,
1984) (See fig.1).
Not all BP metabolites adduct to cellular
macromolecules. As a matter of fact, only a relatively
small percentage of metabolites are adducted to
macromolecules in the cell (See fig.2). The presence of
an enzyme in rat liver preparations that catalyzed
conjugations with glutathione was first detected in 1961.
Although specific for glutathione, these enzymes have very
wide and overlapping second substrate specificities, and
as well as catalyzing conjugation reactions, the
transferases can also act as transport proteins or as
"suicide" enzymes. In the case of BP metabolism,
potentially harmful electrophilic substrates (such as BP
metabolites) are removed via covalent reactions with the
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Figure 1: A proposed mechanism for BP's entry into the
cell and metabolism to DNA binding intermediates that may















enzyme. At present the conjugation of polycyclic
hydrocarbon epoxides with glutathione is regarded as a
true detoxification reaction. Epoxides that are not
conjugated with glutathione are converted into phenols and
dihydrodiols and these hydroxylated metabolites are often
not sufficiently polar to be excreted as such. Their
polarity is increased by conjugation with glucuronic or
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The first insight into human cancer causation
occurred in the 18th century with clinical observations by
Percival Pott of the association of soot with scrotal
cancer in chimney sweepsr. In the last decade of the 19th
century, the association between occupational exposure to
aromatic amines and bladder cancer was reported, thus
setting the stage for the identification during the 20th
century of other specific carcinogens in the workplace and
the environment (Mendelhson, et al. 1995).
Inununoloov Backaroimd
The immune system consists of a number of organs
and several different cell types. All the cells of the
immune system, tissue cells and white blood cells or
leukocytes, develop from pluripotent stem cells in the
bone marrow. These haemopoietic stem cells also give rise
to the red blood cells. The production of leukocytes is
through two main pathways of differentiation. The
lymphoid lineage produces T-lymphocytes and B-lymphocytes
while the myeloid pathway gives rise to mononuclear and
polymorphonuclear leukocytes as well as platelets and mast
cells. Platelets are involved in blood clotting and
inflammation while mast cells, similar to basophils in
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blood, and found in tissues, are involved in
hypersensitivity states. There is a third population of
lymphocytes, also known as null cells or non-T/non-B cells
that develop along a less well known pathway (Weir and
Stewart, 1993) .
At the time stem cells leave the bone marrow they are
unlikely to have expressed their antigen-specific
receptors (although this is the subject of intense
debate).
Pre T-cells exit from blood and enter the thymic
cortex, where they divide extensively and acquire some of
the cell surface markers characteristic of T-cells. In
the medullary region of the thymus, most of the T-cells
have properties normally associated with mature peripheral
T-cells. The thymus consists of lobules of loosely
packed epithelial cells covered by connective tissues.
The outer part of each lobule, the cortex, is densely
populated with thymocytes, i.e. lymphocytes. According to
Tizard (1992), thymic epithelial cells present self
antigens with MHC antigens to thymocytes to clonally
anergize (and/or delete) the self reactive lymphocytes.
In immune response assays for thymic T-cells, it is
primarily the medullary cells that are reactive, though
cells from other regions of the thymus may also react to
a lesser extent. Attempts to determine which cells exit
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from the thymus and where have been inconclusive, although
it is clear that mature T-cells leave via blood because
there is essentially no lymphatic drainage from the
thymus. Despite the extensive proliferation in the thymic
cortex, few cells leave the thymus from this region in
normal adult animals; estimates are that greater than 90%
of dividing (cortical) thymocytes die in situ. The major
cell types of the immune system are the macrophages and
the lymphocytes. Macrophages, as non-antigen specific
cells, are responsible for concentrating and presenting
antigen to the lymphocyte in the generation of antigen-
specific responses. They are also responsible for the
production and secretion of biologically active components
(cytokines) that modify or modulate lymphocyte
responsiveness and initiate increased production of
nonspecific factors such as the acute phase reactant
proteins (Langman, 1989).
In adult virgin animals, T-lymphocytes that
participate in the cellular immune response are derived
from bone marrow stem cells. These hemopoietic cells
migrate to the thymus where they are "educated" and take
on their specificities. The decisive studies of Miller on
the effects of neonatal thymectomy in mice established
that the formation of T-cells depends heavily on the
intact thymus and that the main function of the thymus is
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to produce mature, functional T-cells and release these
cells into the peripheral lymphoid tissues (Miller, 1951).
There is also support for the hypothesis that T-
lymphocytes may also pass through the liver (during
ontogeny) sometime before maturity (Roitt, 1985).
Lymphocytes responsible, in the main, for the
cellular responses are of thymic origin and termed T-
cells, while those that mature into antibody-forming cells
are bone-marrow derived and termed B-cells (Hancock,
1985) . Unlike immunoglobulins (antibodies) which interact
with free antigens, T lymphocytes recognize antigens on
the cell surface only in the context of Major
Histocompatibility Complex (MHC) antigens (MHC
restriction)(Roitt, 1992).
Lymphocytes are produced in the primary or central
lymphoid organs (thymus and adult bone marrow) at a high
rate (10® per day). Some of these cells migrate via the
circulation into secondary lymphoid tissues (spleen, lymph
nodes, tonsils, etc.). Lymphoid cells represent about 20%
of the total white blood cells present in the adult
circulation (Roitt, 1992).
Lymphocytes are the antigen-specific cells of the
immune system acting via antigen-specific receptors on
their cell surface. Lymphocytes express a large number of
different "markers", or antigens on their surfaces which
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can be used to distinguish cell populations (Roitt, 1992) .
A definitive T-cell lineage marker is the T-cell
antigen receptor (TCR). There are presently two defined
types of TCR; TCR-2 is a heterodimer of two disulphide
linked polypeptides, alpha {a) and beta {(3) ; TCR-1 is
structurally similar but consists of delta (6) and gamma
(7) polypeptides. Both receptors are associated with a
set of five polypeptides, the CD3 complex, which is part
of the T-cell receptor (TCR-CD3) complex. Approximately
90% of blood T-cells express TCR-2 and about 15% express
TCR-1 (Roitt, 1992) .
The TCR-2 cells can be subdivided into two distinct
non-overlapping populations: a subset which carries the
CD4 marker and mainly "helps" or induces immune responses-
a T helper (T^) , and a subset which carries the CDS marker
and is predominantly cytotoxic-a T cytotoxic cell (T^,) .
CD4 cells have been functionally divided into two further
subsets: T^-l and Th-2. T^-l cells mediate several
functions associated with cytotoxicity and local
inflammatory reactions and they secrete primarily IL-2 and
IFNy.
Th-2 cells are more effective at stimulating B cells
to proliferate and produce antibodies, and they secrete
primarily IL-4, IL-5, IL-6 and IL-10 (Roitt, 1992).
Approximately 80-85% of adult thymocytes are defined
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by coexpression of the surface molecules, CD4 and CDS, and
are initially located in the cortical region of the
thymus. (CD4+ CD8+ cells are called double positive
cells). This is the first distinct population of
thymocytes to appear in the thymus. It is widely accepted
that the bulk of double positive cells die in the thymus.
The experimental evidence comes from in vivo studies that
examine the reutilization of thymidine label, thymic
input/output, and turnover rates. It has been proposed
that this intrathymic cell death is largely the result of
nonproductive TCR gene rearrangements or because they fail
positive selection, hence are negatively selected, i.e.
they die (Fowlkes and Pardoll, 1989).
The next population of thymocytes to appear in fetal
development after the double positives are CD4+8-,
followed shortly by the CD4-8+ thymocytes. Single
positive thymocytes are similar to peripheral CD4+ and
CD8+ T-cells in both phenotype and function; however,
evidence is mounting that these populations may be more
heterogenous than previously believed. Single positive
cells constitute about 10-15% of those in the adult thymus
and reside mainly in the medullary section of the thymus.
In the thymus, virtually all of the CD4+8- cells express
TCR (q!/S) , while only about 1/2 of the CD4-8+ cells express
this TCR. While the ratio of CD4+ to CD8+ is generally 2
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to 1 in the periphery, it is closer to 3 to 1 in the
thymus (Fowlkes and Pardoll, 1989).
CD4+ Tj, cells play several central roles in cell-
mediated immunity: they direct the fine specificity of
the response i.e., determine which antigens and epitopes
are recognized; they are involved in the selection of the
effector mechanisms to be directed against the selected
target antigens; they aid proliferation of the appropriate
effector cell types; and they enhance the functions of
phagocytes and other effector cells. The CD4'" cells
produce molecules that stimulate growth and
differentiation of other cells. These molecules are most
effective over short distances since they will be more
concentrated. This will happen when the two cells
involved are actually joined together in close proximity.
The stimulation of CD4'" T-cells by antigen fragments on
the surface of a responsive cell will greatly increase the
effectiveness of the messenger molecules produced by the
T-cell (Weir and Stewart, 1993) .
Most immune responses are initiated through
recognition of foreign antigen associated with self MHC-
encoded products by T-cells via TCR. The TCR is the
molecule that is responsible for the recognition of
specific MHC/antigen complexes and will be different and
specific for every T-cell (Weir, 1993).
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The TCR consists of a disulfide linked glycosylated
polypeptide consisting of 2 chains, an a and /S chain; each
a transmembrane protein that shows homology with Ig. The
TCR recognizes short peptide fragments of intracellularly
degraded antigens laying in a groove in the most external
domain of class I or II MHC encoded molecules (e.g., on
macrophages or antigen presenting cells). Class I MHC
molecules are expressed on nearly all cells in the body,
but do not necessarily take part in antigen presentation.
The expression of class II molecules is limited to certain
cell types, especially macrophages, B-cells, and dendritic
cells. TCR forms a trimolecular complex with antigenic
peptide and MHC molecules. (Roitt, 1985).
The T cell receptor consists of two variable a and jS
chains associated with several invariant CD3 polypeptides,
together constituting the TCR/CD3 complex. The variable
chains are structurally very similar to immunoglobulin
heavy and light chains. The stoichiometry of the TCR/CD3
complex has been estimated as a, P, y, 5, e, rj (Rao,
1991).
The CD3 polypeptides are required for surface
expression of TCR oi and /3 chains; conversely mutant T
cells lacking an a or ;S chain do not express cell surface
CD3. The CD3 y, 5, and e polypeptides associate rapidly
during biosynthesis and form a core structure for assembly
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of the TCR oi and jB chains. Preliminary evidence for a
role in signal transduction has been obtained for the CD3
g chain. It is well established that T cells show
increased phosphoinositide(PI) turnover in response to T
cell receptor ligand, and the CD3 7j chain has been
implicated in PI turnover through the TCR (Rao, 1991).
The first step in many immune reactions is the
recognition of antigens which are carried on the surface
of invading organisms, but this is only preliminary to the
reactions which follow, aimed at eliminating the source of
the antigen (See fig.4). Foreign antigens must be
"processed" by antigen processing cells and presented by
antigen presenting cells (APC), which are macrophages,
dendritic cells, and less actively, B-cells and
endothelial cells (Tizard, 1992). APC's are a
heterogeneous population of cells and some have a pivotal
role in the induction of functional activity of T^ cells
(Roitt, 1992). These cells phagocytize the antigen and
degrade these antigens into small fragments. These
fragments are then presented on the surface of the APC's
and recognized by the T-cells. Support for this notion
stemmed from findings that peptides cleaved from native
antigens are strongly immunogenic. After feeding native
antigen to APC's, effective presentation to T-cells
requires a lag period of about 1 hour at 3 7°C (Sprent and
21
Figure 4: Overview of T cell response in the




Webb, 1987). T-cells recognize cell-bound antigen in
association with MHC molecules. MHC class I and II
antigens act as guidance systems for T-cells, and this
process is called MHC restriction (Roitt, 1985).
Originally, it was thought that protein fragments from the
antigen were present in close proximity to the surface MHC
molecule where they could be simultaneously contacted by
TCR. However, from studies with influenza virus, it was
learned that a cytotoxic T-cell (T^) response could be
triggered when short synthetic peptides were mixed in
vitro with antigen-presenting cells carrying the
appropriate MHC class I molecules. Only T-cells bearing
receptors that bind to self MHC (MHC molecules specific to
T-cells) within an appropriate affinity range are selected
in the thymus for further development (Townsend and
Skehel, 1984).
During lymphocyte development, these cells pass
through a stage at which they are highly susceptible to
the induction of tolerance, with a relatively low dose of
antigen. Tolerance is the specific lack of an immune
reaction to a particular antigen, which may be induced
naturally or by particular injection schedules of that
particular antigen. Since the whole immune system is
immature in the earliest stages of neonatal life, a
newborn animal is particularly susceptible to the
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induction of tolerance (Tizard, 1992).
Immunological tolerance, a state of immunological
unresponsiveness, may in many respects be viewed as a form
of immunosuppression. Strictly speaking, tolerance has
been the term applied to that state in which exposure to
an immunogen (an antigen capable of normally inducing
immune reactivity) does not result in an immune response.
Under these circumstances, a "foreign" antigen is
perceived in the same manner as a "self" antigen and no
response against that specific antigen is mounted
(Bellanti, 1985).
If the thymocyte reacts adversely to the self and/or
MHC antigens, putatively, it is destroyed by apoptosis
(negative selection). Negative selection was initially
proposed to explain how the developing immune system
learns to distinguish self from non-self, i.e., to react
to foreign antigens yet be tolerant of self antigens.
Probably the most compelling evidence that tolerance
occurs during intrathymic development was the
demonstration that T cells maturing in fetal thymic organ
culture react against allogeneic stimulator cells to a
significantly greater extent than against syngeneic
stimulator cells. Subsequently, the postulate that
negative selection might involve recognition of thymic
(self) MHC antigens was borne out by experiments which
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showed that developing T cells are tolerant to self-
nominal antigens only in the context of thymically
expressed MHC antigens (Fowlkes and Pardoll, 1989).
The surviving thymocytes, which do not recognize self
as foreign, are positively selected and are subseaquently
stimulated to proliferate in the presence of specific
foreign antigen (Tizard, 1992). This selective process
appears to operate during thymocyte development which
favors T-cells capable of responding to foreign antigens
in association with self-MHC antigens. One popular
resolution of this paradox of positive and negative
selection is that the affinity of the TCR for MHC
determines whether positive or negative selection occurs.
Weak interactions (recognition and binding) between TCR
and antigen-MHC would be sufficient to mediate positive
selection, whereas higher affinity interactions would lead
to negative selection. A second possibility is that both
positive and negative selection result from relatively
high affinity interactions but there are qualitative
differences between the self-peptide/MHC complexes which
mediate positive and negative selection (Robey and
Fowkles, 1994).
The commonly proposed mechanism to account for
positive selection (cells that are programmed against any
conceivable foreign antigen) presumes that TCR's reaction
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with self-MHC + antigen will have at least a low affinity,
or insufficient binding capacity, for antigen:self-MHC
alone. Thus, TCR's with any affinity (low or high) for
MHC antigens expressed on the thymic stroma would be
engaged, signaling the thymocyte to either expand or be
salvaged from dying. The thymocyte would then pass into
a negative selection stage in which a cell bearing TCR
with high affinity for thymic MHC (self) antigens would be
deleted. The result is that only clones with low affinity
for self-MHC (and high affinity for non-self-MHC +
antigen) survive both positive and negative selection
(Fowlkes and Pardoll, 1989).
What is the mechanism by which a low affinity TCR/MHC
interaction may trigger a different developmental outcome
than a higher affinity interaction? One possibility is
that thymocytes may make qualitatively different responses
to different intensity signals. For example, a weak
interaction of TCR with antigen-MHC might trigger a
maturation program, whereas stronger interactions may
activate self destruction of self reactive T cells in the
thymus (Robey and Fowlkes, 1994). In positively selected
cells, the TCR gives specificity for antigen recognition
to the T-cell but other cell membrane molecules are needed
for T-cells to function. The CD3 complex (T3 in man) is
present on all T-cells and has a constant structure. It
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is composed of five non-covalently associated polypeptide
chains that have a negative charge in their transmembrane
portion. These polypeptides are thought to be important
in the association of the complex with the T-cell receptor
which has a positively charged residue in the
corresponding region. The CDS complex is thought to be
involved in signal transduction. Residues present in the
cytoplasmic domain are susceptible to phosphorylation,
which is a commonly used activation signal (Weir and
Stewart, 1993). There are several different T-cell
subsets developing in the thymus that differ in function
and/or specificity. These subsets are distinguishable by
unique surface antigens. In mice, Tj, (helper) possess Lyl,
L3T4 antigens; T^ (delayed type hypersensitivity) possess
Lyl, L3T4, but not Lyt2; T^ (cytotoxic) and Tg
(suppressor) possess Lyt2, Lyt3 but not L3T4 (Tizard,
1992) .
There are other surface antigens present along with
accessory antigen molecules, called cell adhesion
molecules. They also participate in the cellular immune
response and are important in the initial stages of cell
activation, i.e. LFA-1, LFA-2, intracellular adhesion
molecule(ICAM). Almost all T-cells possess the surface
marker Thy-1. T^ and Tg cells mainly recognize Class I
MHC molecules and T^ recognize Class II MHC (Marrack,
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1988) .
A number of less well understood adhesion molecules
may also be involved in the interaction between the T-cell
and its target. These molecules, including CD2 (LFA-2)
and CDllb/CD18 (LFA-1) , help stabilize the binding of the
TCR to the target but do not contribute to the specificity
of the interaction. CD2 interacts with CD58 (LFA-3) and
the CDllb/CD18 molecule binds to ICAM-1 (Weir and Stewart,
1993) .
The first stage of CMI, activation, depends on signal
transduction mediated through the T cell antigen receptor.
The second stage is progression of the activated T cell
through G1 phase into S phase, a process mediated by
binding of the T cell growth factor interleukin 2 (IL2) to
its high affinity receptor. For the Tha subset of helper
T cell clones, the proliferative stimulus may be provided
by the growth factor interleukin 4 (IL4)(Roitt, 1985).
A distinguishing feature of T cell activation is its
dependence on cell-cell contact. Thus, activation of T
cells by antigen requires accessory cells or target cells
capable of forming and presenting the appropriate
antigen/MHC complexes. If T cells do not encounter the
requisite MHC antigens on the surface of target cells, the
interaction is quickly terminated. In contrast if the
targets express the appropriate antigen, the interaction
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is stable and persists for several minutes. This is
partly a result of stronger binding by auxiliary molecules
such as leucocyte function antigen 1 (LFA-1) on the T cell
surface to their ligands on the target cell surface. The
lethal hit, as can be observed at this time, is delivered
within 10 minutes of T cell-target cell contact, and the
T cell can then detach from the surface of the target cell
and go on to sample other potential targets (Rao, 1991).
The antigen specific interactions mediated by T-cells
and antigen presenting cells (APC) determine the antigen
specificity of the cellular immune responses. However,
T-cells also interact with other cells via lymphokines
which they release following activation. Although the
actions of lymphokines are antigen non-specific, they
usually act with the greatest effect on target cells in
the immediate vicinity of the active T-cells,• i.e. IL-2
activates mostly T effector cells, IL-4 mostly B-cells of
the immune system. These will act as mediators of antigen
specific immune reactions (Roitt, 1985).
Calcium is required for lymphokine production.
Chelation of extracellular calcium with EGTA greatly
diminished IL2 production by murine T hybridoma cells
during 4h stimulation with antigen-pulsed cells (Rao,
1991) . Since production of IL2 and expression of IL2
receptors are controlled at the transcriptional level.
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this observation suggests that induction of the IL2 and
IL2ra(receptor) genes proceeds by distinct calcium-
dependent and calcium-independent mechanisms, respectively
(Rao, 1991).
At least two consistent early responses to T cell
receptor stimulation have been described. The first is
increased polyphosphoinositide hydrolysis, a bifurcating
signal transduction pathway resulting in calcium
mobilization and activation of protein kinase C. Calcium-
dependent kinases distinct from protein kinase C are also
likely to be activated. Protein kinase C is thought to
mediate a wide variety of later responses including
cytoplasmic alkalinization via the Na'^/H^ antiporter and
induction of activation-associated genes (Rao, 1991).
The second early response is the increased tyrosine
phosphorylation of several proteins including the CD3 zeta
chain. This response presumably depends on activation of
one or more tyrosine kinase and/or the inhibition of
tyrosine phosphatases. It does not depend on the presence
of active protein kinase C, since it occurs in cells
depleted of kinase C by prolonged exposure to phorbol
ester. However, its dependence on phosphatidylinositol
turnover or calcium mobilization has not been evaluated
(Rao, 1991).
31
Unlike T cell receptor ligands, IL2 does not
stimulate phosphotidylinisotol turnover, inositol
phosphate production or calcium mobilization in responsive
T cells, although it does activate one or more protein
tyrosine kinases. Similarly, unlike the responses to T
cell receptor stimulation, responses to IL2 are
independent of loss or depletion of protein kinase C.
However, much less is known about the second messenger
pathways activated by IL2 (Rao, 1991).
The involvement of one or more protein kinase C
isozymes in certain aspects of TCR-mediated signalling has
been fairly well established. Translocation of protein
kinase C from the cytosol to the membrane occurs after
treatment of T cells with phorbol esters or anti-receptor
antibodies; sustained translocation and activation of
kinase C appear to be required for a maximal T cell
response. Inhibitors of protein kinases, many of which
are relatively specific for protein kinase C, inhibit
proliferation, gene induction, and target cell lysis in
response to antigens, lectins and anti-CD3. T cells
depleted of kinase C by prolonged treatment with phorbol
esters show greatly diminished TCR-mediated responses,
including proliferation, gene induction and lymphokine
secretion, and cytolysis and serine esterase release (Rao,
1991).
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It should now be evident as to the importance of T-cell
markers (surface antigens) in T-subset identification and
in participating in the immune response. Recall that the
TCR, MHC and other T-cell surface molecules must be
present in order for an efficient cellular immune response
to take place. This fact exemplifies the importance of
proper T-cell marker expression.
Metabolism background
The metabolic interface between the environmental
PAH'S and the biological organism is the cytochrome P-450
enzyme system. The alternatives of metabolic activation
and detoxification present the biologic paradox of cancer,
namely, that the enzymes that activate carcinogens are
members of the same family as enzymes that result in their
detoxification. These enzymes, the mixed function
oxidases, ubiquitous to all tissues but found mostly in
the liver, are members of a large superfamily of
cytochromes responsible for oxygenations necessary for the
biosynthesis of cholesterol , steroid hormones, and for
the oxygenation of xenobiotic chemicals in phase 1 of
their metabolic detoxification and activation (Stevenson,
1990).
Cytochrome P-4501A1 (P-448) catalyzes the oxidation
of benzopyrene. This "new species" of cytochrome P-450
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was distinguished from its "normal" counterpart by the
different pH dependency of its ethyl isocyanide-difference
spectrum, and it was soon found that this cytochrome had
an absorption maximum at 448„„ instead of 450nn,, and the
alternate name of cytochrome P-448 gained wide acceptance
(Sato and Omura, 1978). These cytochromes (P-450) accept
only planar, rigid molecules, which they oxygenate in
conformationally hindered positions that do not readily
allow subsequent phase 2 metabolism and detoxification
(Stevenson, 1990) . Aryl hydrocarbon hydroxylase activity,
the human BP metabolizing enzyme has been found in human
liver, skin, placenta, lymphocytes, monocytes and lung
macrophages (Sato and Omura, 1978). Differences in the
activities of these enzymes in individuals may be directly
related to their susceptibility to carcinogenesis by the
PAH'S (Gelboin, 1987).
The enzyme catalyzed formation of bay-region diol
epoxides of BPDE involves epoxidation by cytochrome P-450
at the 7,8-position of BP to yield preferentially the BP-
7, 8-epoxide (See fig.5). Hydrolysis of the corresponding
7,8-dihydroxy-7,8-dihydro-BP followed by a second
epoxidation at the 9,10-position yield 7,8,9,10-BPDE ( ( + ) -
anti-BPDE)). Extensive studies of anti- and syn-BPDE have
established that (+) anti-BPDE is by far the most active
form in mammalian systems and have led to the suggestion
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Figure 5: Benzo(a)pyrene metabolism by epoxide hydrolase




HjO I EpoxideI Hydrolase
(-) BP-7,8-Epoxide
H O I Epoxide^ I Hydrolase




(+) anti BP 7,8 -
diol-9,10-epoxide
(-) syn BP 7,8 -
diol-9,10-epoxide
(-) anti BP 7,8 -
diol-9,10-epoxide
{+) syn BP 7,8 -
diol-9,10-epoxide
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that the high biological potency of this isomer is
associated with unique structural properties of the
adducts that result from covalent binding of the diol
epoxide to DNA (Jernstrom and Graslund, 1994).
The sequence of enzyme action in BP metabolism is as
follows. The initial oxygenation is catalyzed by the
microsomal MFO's. This results in the formation of
epoxides at the 2,3-, 4,5-, 7,8-, and 9,10-positions. The
most stable of these, the 4,5-epoxide, has been isolated
under special conditions. The formation of the 4,5-,
7,8,and 9,10-epoxide intermediates can be deduced from the
presence of all three of the corresponding dihydrodiols.
These are formed by the action of epoxide hydratase on the
epoxide intermediates. Further evidence for this
mechanism, are the findings that a hydratase inhibitor,
1,2-epoxy-3,3,3-trichloropropane (TCPO), completely
eliminates dihyrodiol formation and that the readdition of
a partially purified epoxide hydratase results in the
appearance of the diols. Some or all of the above epoxide
intermediates may be converted to phenols. The 1,2-
epoxide may also be formed and may be the precursor of 1-
phenol, which was detected as a metabolite (Gelboin,
1980) .
It was reported in 1950 that epoxides might serve as
reactive intermediates in PAH metabolism, but it was
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Miller in 1951 who reported that BP or its metabolites
became covalently bound to proteins in mouse skin (Miller,
1951) . However, the metabolic activation of PAH's did not
become evident until the 1960's when their covalent
binding in vivo to mouse skin was demonstrated and found
to correlate with carcinogen potential (Brookes and
Lawley, 1984).
Although the participation of monooxygenases in PAH
metabolism was recognized earlier, Grover and Sims (1968),
and Gelboin (1969) provided the first direct evidence that
the cytochrome P-450 dependent oxidation of a PAH, BP,
resulted in a reactive intermediate that covalently bound
to protein and DNA.
In 1973, Borgen et.al. reported more extensive
covalent binding of hydrocarbon metabolites to DNA when
BP-7,8-dihydrodiol was metabolized by hamster liver
microsomes than when BP or several of its metabolic
products were metabolized by this system. Subsequent
studies by Weinstein, et.al.(1976) and others demonstrated
that the (+) enantiomer of BP-7,8-diol-9,10-epoxide
covalently bound to the 2-amino group of guanine in
nucleic acids, was the major nucleic acid adduct observed
when BP was metabolized by bovine bronchial explants and
by explants or cultured cells from human bronchus, lung,
and colon (Conney, 1982).
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In 1974, Sim showed that a 7,8-diol-9,10-epoxide was
the metabolite of BP responsible for binding to the DNA.
Many BP derivatives and metabolites have been tested for
mutagenicity and the diastereomeric BP-7,8-diol-9,10-
epoxide is the most potent mutagenic derivative which, is
suspected, leads to carcinogenesis (Sims, 1974).
In 1977, Jeannette et al. detected nucleoside
adducts from the in vitro reaction of benzo(a)pyrene-7,8-
dihydrodiol-9,10-oxide and BP-4,5-oxide with nucleic
acids. The covalent binding of BP-4,5-oxide and BP-7,8-
dihydrodiol-9,10-oxide to nucleic acids was investigated.
The 9,10-oxide reacted extensively with guanosine,
adenosine and cytidine residues. Alkaline or enzymatic
hydrolysis of the modified nucleic acids and subsequent
chromatography on Sephadex LH-20 columns yielded BP-
nucleotide adducts. These were enzymatically converted to
the corresponding nucleosides which were resolved into
several distinct components by high pressure liquid
chromatography (HPLC) and evidence was obtained for the
presence of multiple nucleoside adducts (Jeannette et al. ,
1977) .
Conney (1982) reported that BP-7,8-diol-9,10-epoxide
was the most mutagenic compound tested in S. typhimurium
bacteria when other PAH's were tested.
In humans and E. coli bulky carcinogen adducts are
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repaired in the cell by the nucleotide excision repair
system. It is expected that the different structures of
the adducts formed by the four BPDE isomers {± anti and
syn) are probably recognized with different efficiency by
the repair enzymes. This mechanism involves placement of
two single-strand nicks on the damaged strand on either
side of the modified base. In human cells, these nicks on
the damaged strand are located about 21 and 5 nucleotides
5' and 3' to the lesion, respectively. Excision is
completed by release of the damaged segment in a reaction
that is carried out by helicase(s) to unwind the duplex
DNA and single strand binding protein(s). The resulting
gap then is filled in by DNA polymerase and proliferating
cell nuclear antigen is needed for this step. Finally,
DNA ligase seals the remaining two nicks (Mendelhson et
al. , 1985) .
Experimental Background
Several investigators have demonstrated that exposure
of experimental animals to chemical carcinogens,
especially PAH's, leads to suppression of humoral and
cell-mediated immune functions ( Urso and Gengozian, 1980;
Urso and Gengozian 1984; Harris, 1985; Urso, et al.
1986;) . Animals injected with PAH's show an increased
susceptibility to the growth of tumors; however, a causal
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relationship between immune competency and tumorigenesis
has not yet been established. BP has been shown to lead
to a sustained immune suppression and an increased
frequency of tumors later in life in mice (Urso, 1980).
Various aspects of T-cell mediated immunity have been
shown to be deficient in tumor-bearing individuals. A
recent study by Ochoa (1992) has suggested that this may
be due to a deficit in the ability of T-cells to transduce
signals on stimulation by antigen.
The finding by Urso and Gengozian (1980) showed the
immuno-suppressive and carcinogenic potential of
benzopyrene following exposure during midpregnancy.
C3H/Anf pregnant mice 9-14 weeks old were injected
intraperitoneally (i.p.) with 100 or 150 ug/g body weight
(bw) of BP dissolved in corn oil. BP exposed progeny
showed a markedly suppressed immune response (measured by
anti-SRBC and PFC response) throughout the entire
experimental period (78 wks--approximately 2/3 of the
animals life span). The frequency of tumor development
showed an 9-10 fold increase in BP treated mice in
comparison to the control (untreated) . This kind of
information suggests that early modification of the immune
system induced by BP may be relevant to increased tumor
incidence observed late in life.
BP has been shown to lead to a 30-70% suppression of
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BP has been shown to lead to a 30-70% suppression of
the anti-SRBC, PFC response in the prenatally exposed
progeny (Urso and Gengozian, 198 0; Urso and Gengozian,
1982)and in adult mice (Stjernsward, 1969). The immune
suppression induced after prenatal exposure is sustained
for the greater part of the animal's life span (18
months). Urso, et.al. (1992) have shown that this
carcinogen, following prenatal exposure, induces a
prolonged suppression of cell-mediated immunity as
measured by T-cell proliferation in the mixed lymphocyte
response (MLR). In the MLR, lymphocytes (responder cells)
are treated with allogeneically different cells
(stimulator cells) inactivated by X-rays or mitomycin C.
The responder cells recognize foreign antigen in the
stimulator cells and proliferate in accordance with a
normal immune response. Cell proliferation is measured as
an index of immune competency.
Urso, et al. (1986) showed that for virgin mice
inhibition of the PFC response and the MLR occurred when
their spleen cells were exposed in vitro to a wide range
of BP concentrations from lO’^M to 10'®M. The response of
antibody (plaque) forming cells occurs when SRBC is
introduced to mice. As explained above, the virgin mice's
macrophages phagocytize the antigens on the SRBC's and
present these antigenic peptides on its surface. Tj, cells
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then recognize the antigen and MHC complex on the
macrophage and they release lymphokines that activate B-
cells, to produce antibody (Urso et al., 1986). Maximum
depression, without loss of cell viability, of the
responses occurred at lO'^M for PFC production (47% of
controls) and for the MLR (19% of controls) . Virgin adult
mice were used as the source of responding splenic
lymphocytes. SRBC were used to stimulate these
lymphocytes in vitro for PFC production. In MLR,
splenocytes from allogeneic adult mice were used as target
stimulator (S) cells for responder splenocytes.
This data extends previous observations on the
suppressive effect of BP on cell-mediated components of
the immune response. The depressed MLR provides support
for BP induced dysfunction in the T-cell population. The
concentrations of BP used are comparable to the amount
calculated to enter the fetus after maternal injection
with 150 /xg/gBW (Urso et al.,1986).
Detection of adducts and methodology
Poirier and Santella (1980) quantitated B(a)P
deoxyguanosine adducts by radioimmunoassay (RIA). Calf
thymus DNA was conjugated to BPDE. Rabbits were then
immunized with modified DNA coupled to methylated bovine
serum albumin (BSA„,et) the resulting antiserum was
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utilized in a competition RIA for the quantitation of
products of BP covalently bound to DNA. The antiserum was
specific for both native and denatured immunogen DNA's and
the major isolated BP binding product, but it did not
recognize BP or unmodified DNA. The modified DNA (BP-DNA)
was detected in quantities as low as 2pmol of adduct.
Santella and Lin (1984) have produced monoclonal
antibodies to DNA modified by a BP diol epoxide. The
monoclonal antibodies were obtained after fusion of mouse
myeloma cells and spleen cells of BPDE-DNA-BSA immunized
mice. The antibody produced from the spleen cells of a
BPDE-DNA immunized mouse recognizes BPDE-DNA, N2-
acetylaminoflourine or 1-nitropyrene modified DNA or BPDE
tetraol. The monoclonal hybridoma line was characterized
in an ELISA test (Santella and Lin, 1984).
Since people of certain occupations are exposed to
high concentrations of BP, Shamsuddin et al. (1985) used
ELISA and Ultra Sensitive Enzyme RadioImmunoAssay (USERIA)
to measure BPDE-DNA adducts in WBC's from two of these
occupational groups. Seven of 28 samples from roofers and
7 of 20 from foundry workers were positive for BPDE-DNA
adducts.
In a group of nine volunteers without these
industrial exposures to BP, the two positive DNA samples
were from cigarette smokers. Control DNA obtained from
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human lymphocyte cell line RPMI 4265 was negative. These
results indicate that the metabolic activation of BP and
formation of BPDE-DNA adducts occurs in humans (Shamsuddin
et al., 1985).
BPDE-DNA adducts have also been detected in
peripheral blood lymphocytes and antibodies to the adducts
detected in serum from coke oven workers. Coke oven
workers are exposed to high levels of carcinogenic PAH's
and are a high risk group for lung cancer. The presence
of these adducts were measured in DNA from peripheral
blood lymphocytes by synchronous fluorescence spectroscopy
(SFS) and enzyme RIA. About 2/3 of the workers had
detectable levels of BPDE-DNA adducts. Antibodies to the
adducts were also found in the serum of 27% of the
workers. Adducts or antibodies were not detected in the
control, non-smoking laboratory workers. DNA adducts
indicate exposure to BP and its metabolic activation to
metabolites that covalently bond to and damages DNA
(Harris, 1985).
The immunological consequences from exposure to BP
during pregnancy has been investigated by Urso
et.al.(1992) Progeny and maternal immune status after BP
exposure of mothers at mid-pregnancy is disrupted in fetal
liver (FL), spleen and thymus during pregnancy and
postnatally. Mice suffer deficiencies in splenic and
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thymic MLR and disorientations of T-antigen expressing
cells, punctuated by increases in Lyt2, especially in FL.
FL Lyt2 does not appear to suppress MLR, while Lytl
mediates suppression. Maternal macrophages and progeny B-
cells are also functionally abnormal. Thus, BP induces
generalized immune deficiency that may affect ontogeny and
which is potentially deleterious to health. After in
utero exposure to BP, tumor incidence in BP exposed
progeny was 9-10 fold higher than in those treated with
corn oil alone from 1-24 months of age. A severe and
sustained suppression in MLR and PFC response also
occurred from the 5th-18th month. These data strongly
suggest that in utero exposure to BP alters the
development of components needed for establishing
competent humoral and cell-mediated functions.
The immunodeficiency exhibited, particularly in the
T-cell compartment (MLR) before and during the increase in
tumor frequency, may provide a favorable environment for
the growth of nascent neoplasms induced by BP (Urso and
Gengozian, 1984).
Objectives and Purpose
The purpose of this research is to determine if T-
lymphocytes from BP exposed mice possess BPDE-DNA adducts
and to elucidate whether adduct presence renders those T-
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lymphocytes more immunocompromised than adduct-negative T-
lymphocyte populations.
The specific aims of this project are to:
a. synthesize BPDE-DNA-BSA adduct conjugate
b. obtain and purify rabbit anti-conjugate
antibodies
c. identify T-cells containing the adduct, using the
above antibodies by FACS scan
d. test functional profiles of adduct positive cells
by the MLR assay
In summary, the hypothesis to be tested is: T-cells
from BP treated mice contain BPDE-DNA adducts and these
adduct positive T-cells have compromised abilities in the
cellular immune response to antigen.
Surface antigens play an important role in the immune
response of T-cells; therefore, if the presence of the
adduct affects the expression or function of these surface
antigens, this may be one possibility for BP's suppressive
effects on cell-mediated immunity.
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RATIONALE AND APPROACH
Cancer, particularly in advanced stages, frequently
has been shown to be associated with substantial
deficiencies in the function of various aspects of the
cellular immune system (Mendelhson, et al. 1995) . Our
experiments have concentrated on disruption of cell-
mediated immune functions in mouse (progeny) following in
utero exposure to BP. In addition to being a potent tumor
causing agent, BP is capable of inducing immunodeficiency
in virgin mice, pregnant females and their progeny. In
view of the aforementioned research on how BP suppresses
cell-mediated immunity and the ability of the major BP
metabolite, BPDE, to adduct covalently to DNA, the purpose
of this study was to analyze the effect of BP on T-cells
and their ability to respond to antigen in the cell
mediated immune response. Nucleotide alteration by BPDE
may affect not only the conventional expression of surface
markers (e.g., L3T4, Lyt2) but also the functional
capabilities in recognizing endogenous (tumor) or
exogenous (infectious agents) antigenic profiles. Progeny
mice were used because our research has concentrated on T-
cell ontogeny and the pathway that T-cells take in
development. Studies by Juchau, et al. (1980) have
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indicated that the liver and adrenal gland represent the
major organs of P-450 dependent mono-oxygenation during
prenatal life in humans. It has also been shown that
human fetal liver can metabolize BP to DNA binding
metabolites (Berry et al.,1977). Jones and Fantel (1977)
have demonstrated the capacity of several human fetal
tissues to catalyze the conversion of BP to intermediary
metabolites that were mutagenic in bacteria. In the
developing embryo, there is no well-organized bone marrow,
and hematopoiesis occurs in the fetal liver (Langman,
1989). This pathway (which can be studied in developing
fetuses) may be parallel to the pathway of BP metabolism.
Since it is commonly accepted that the response against
tumors involves primarily T-cell mediated functions, the
elucidation of this problem may prompt further insight on
the role of the immune system on possible pathways or
mechanisms for tumor formation (Urso and Johnson, 1987).
The approach that was employed was to synthesize the
BPDE-DNA-BSA conjugate and immunize rabbits to obtain
antibody against the conjugate. The antibodies obtained
from the serum was affinity purified and quantitated by
the ELISA technique.
The anti-conjugate antibodies was used followed by
secondary antibody labelled with propidium iodide dye
(specific for DNA) and FITC to treat BP, normal, and corn
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oil (vehicle) T-cells to see whether these cells contain
the adduct. From the adduct-containing cell population,
flow cytometric analysis was performed to test for cell
surface antigens (or the absence thereof).
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MATERIALS AND METHODS
Preparation of cells for various experimental procedures
To obtain cells, spleen, thymus or fetal liver tissue
were placed in a petri dish with IXPBS. A 3cc plastic
syringe was filled with PBS and injected into the flat
end of spleen or liver using a 25 gauge needle and pushed
down to the end. PBS was injected and the tissue placed
in a nylon sleeve and rubbed gently with a glass rod. PBS
with cells were removed from the petri dish with a Pasteur
pipet. For thymus cell preparation, tissue was teased
with two 18.5 gauge needles until cells were separated
from each other. They were then removed from dish with
Pasteur pipet and filtered through a nylon sleeve to
eliminate cell aggregates. For fetal liver cell
preparation, ficoll-hypaque (ficoll-sodium diatrizoate)
(Sigma) isolation of T cells was accomplished by making a
50% hypaque solution in water and a 7% solution of Ficoll.
The ficoll-hypaque solution was then made in a 1:1:1.5
ratio of water, hypaque, ficoll. Equal volumes of ficoll-
hypaque solution was used to separate equal volumes of
cell suspension. After centrifugation of cells at 1800
rpm for 8 min, the cloudy buffy coat of cells was
extracted and used as the source of fetal liver T-cells.
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DNA isolation
DNA isolation was performed according to the Oncor
non-organic DNA extraction kit manual. Teased (isolated)
cells in PBS were placed in a 15ml polystyrene tube and IX
wash solution was added to a final volume of 9ml. The
tube was inverted to mix the contents, which were then
incubated 15 min at room temperature, centrifuged at
lOOOxg for 20 min at 18°-26°C. The supernatant was
pipetted off and saved in a 15ml polystyrene tube. Two
volumes of ethanol (at room temp) were added and the tube
was inverted gently until the DNA precipitated and
appeared as a white mass. DNA was retrieved by spooling
with a loop or Pasteur pipet, allowed to air dry 4-5 min.
It was then dipped in 70% ethanol and air dried 4-5 min.
To a 1.5ml microcentrifuge tube about 400ul suspension
buffer II were added and the loop with DNA placed inside
the tube. The loop was broken off if the DNA did not
dissolve immediately into the solution and the tube
incubated at 50°C overnight in water bath. Next, the tube
was vortexed, the loop was removed (without DNA on it) and
the DNA was measured by using 1:50 dilution. The formula
used to quantitate the DNA was /xgml'^ DNA = A280 X 500.
Reaction of nucleic acids with BPDE
The methodology for this procedure is similar to that
of Jeannette et al. (1977) . Solutions containing about
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Imgml"^ DNA in 0.4ml water or suspension II buffer were
mixed with an equal volume of acetone.
Ome mg BPDE in 0.2ml acetone was added to the mixture
and incubated for 18hr at 37°C in the absence of light.
Unbound BPDE was removed by ether extraction 3X at 2500rpm
for 10 min. Nucleic acid was precipitated from the
aqueous phase by adding 0.1 vol of 2M sodium acetate (pH
5) and 2.5 vol ethanol. The mixture was left at -20°C
overnight. The precipitate was collected by
centrifugation at BOOOrpm and the pellet was dissolved in
0.10ml water. Absorption spectra on aliquots were
determined in water (Jeannette et al. , 1977) . Adduct
presence was determined by acid hydrolysis with 0.IM HCl
and the hydrolyzed adduct was read on a synchronous
fluorescence spectrophotometer with emission set at 300nm
and excitation at 337nm with the adduct peak being at
about 374-382nm in wavelength (Vahakangas et al., 1988) .
Preparation of innnunizina antigens
Modified DNA (BPDE-DNA) was dissolved in O.IOM NaCl
to a concentration of 500/igml'^, based on a wavelenth of
■^28onm- The DNA was denatured by boiling the solution at
100°C for 10 min and chilled rapidly in ice water. Then
a 1% solution of methylated BSA in water was added with
mixing until the final weight ratio is 1 (Plescia et al.,
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1964) . A volume of the complex was emulsified with a
volume of incomplete Freund's adjuvant or Titermax. The
emulsion was injected into the gastrocnemius muscle of the
rabbit (after it has been shaved) or injected
subcutaneously in the pelvic area (See fig. 6).
Bleeding of rabbit
The animal was placed in a restraining box with the
head and ears protruding. Wintergreen oil was applied to
the marginal area of the ear. A butterfly syringe was
inserted into the medial ear artery and blood was
collected (about 10-35ml). To stop bleeding, pressure or
an ice pack was applied to the ear.
Precipitation of antibody
Antibody was obtained from the antisera by using the
EZ-Sep polyclonal rabbit antibody purification kit. This
procedure yielded approximately 85-90% globulin rich sera
without other serum proteins such as rabbit albumin.
Briefly, antiserum was added to a 50ml tube with an equal
volume of Buffer A. The contents were mixed and were
allowed to stand at room temperature for 15 min. Then, a
2X starting volume of EZ-SepA solution mix was added, and
the mixture was allowed to stand for 3 0 min. It was
subsequently centrifuged for 30 min at 5000rpm. The
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precipitate was resuspended in a volume of Buffer B equal
to the starting volume of serum. This mixture was allowed
to stand for 15 min. One vol of EZ-Sep B solution was
added and incubations and centrifugations repeated as
with Buffer A. The precipitate was resuspended in
deionized water, allowed to stand 15 min and 1 vol EZ-Sep
B solution was added. The incubations and centrifugations
were repeated as described above. The precipitate was
resuspended in IX PBS and the concentration of antibody-
protein was determined by spectrophotometry at A28onra-
Detecting anti-BPDE-DNA bv ELISA
The ELISA test was performed according to the
directions in a kit provided by Kirkegaard and Perry
Laboratories, Inc. In short, antigen was diluted in IX
coating buffer to about lOugml’^. The antibody was
diluted with 2X distilled water to about 400ugml'^ or
less. One hundred (100) /xl coating solution was added to
the appropriate wells and the plate was incubated 1 hour
at room temperature. The plate was then emptied and
residual liquid was tapped off. Three hundred (300) /xl
block solution were added (Horse serum to block unbound
spots on wells) to each well and allowed to react for 5
min. The plate was emptied and residual liquid tapped
off. One hundred (100) fil primary antibody solution were
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added to each well and allowed to react 1 hour. The
plate was emptied, tapped, and washed 3-5 times with the
wash solution. One hundred (10 0) ixl secondary antibody
were added (goat anti-rabbit Ig peroxidase) to each well
and allowed to react 1 hour. The plate was emptied,
tapped and washed 3-5 times. One hundred (100) jx!
substrate solution were dispensed into each well and color
development was observed (greenish). The plate was read
with a plate reader at 405nn, or by spectrophotometer, and
by visual observation.
Preparation of BPDE immimoaffinitv colTimii
Epoxy-activated sepharose gel (O.Vlg) was suspended
in distilled water and filtered. BPDE 1.5mg were
dissolved in coupling buffer and this solution was mixed
with the gel at 37°C overnight. The unbound ligand was
washed with coupling buffer and the gel was transferred to
IM ethanolamine at 50°C overnight. The gel was washed
with 3 cycles of alternating pH with 0.IM acetate (pH 4)
containing 0.5M NaCl followed by 0 . IM Tris-HCl buffer (pH
8) containing 0.5M NaCl. A gel slurry was prepared with
binding buffer in a ratio of 75% gel to 25% buffer and
poured into a column. The column was flushed with buffer,
carefully avoiding the formation of air bubbles. The
column was equilibrated with IX PBS and rabbit antiserum
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against BPDE-DNA diluted 1:1 with IX PBS and filtered.
The antibody sample was loaded onto the column and 1 ml
fractions collected (See fig. 7). Elution was carried out
with glycine buffer (pH 2.4) and column eluates normalized
with IM Tris. Column eluates were tested for presence of
anti-BPDE-DNA by ELISA with appropriate controls. Column
eluants tested positive for anti-BPDE-DNA activity with no
reactions against DNA alone or BPDE alone (at titers of
>1:1000) . Column effluents had antibody activity against
all antigens tested.
Preparation of cells for flow cytometry
Lymphoid cells were isolated by teasing and/or
Ficoll-Hypaque separation which selects for mononuclear
cells on the basis of density. The cells are fixed with
2% paraformaldehyde in PBS for 1 hour on ice and
permeabilized with 1% saponin in PBS for 1 hour on ice
(Jacob et al., 1991) . The cells were incubated with a 1:10
dilution (approx. 2 fig) of propidium iodide for 30 min
then with 1:10 dilution (approx. 20 fig) rabbit anti-BPDE-
DNA for 3 0 min. The cells were washed and resuspended in
IX PBS. The cells were then incubated with goat anti¬
rabbit IgG 1:10 dilution (approx. 2 fig) (labelled with
FITC or PE) for 30 min, washed 2X and resuspended in PBS.
Cells were analyzed by flow cytometry.
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In the case of FACS sorting, the double positive
cells were gated and sorted by the appropriate lasers in
the FACSorter (Becton Dickinson, San Diego, CA).
Allogenic mixed lymphocyte response assay (MLR)
Thymocyte responder cells from 7 day old progeny
(C3Heb/FeJ) were cultured with irradiated (1000
rads/30X10® cells) splenic stimulator cells for an
allogenic (non-self) MLR. The cells were mixed in RPMI-
1640 tissue culture media at a concentration of 1X10®
cells of both responder and stimulator cells. A total
volume of 200/il per well in a 96 well microtiter plate
(Falcon) were incubated at 37°C and 5% CO2 in a humidified
atmosphere. On the third day of incubation, the cultures
were pulsed with ^H-thymidine 10 /xl(0.5 /xCi) per well,
specific activity 6.7 mCi/mM (Dupont New England Nuclear).
The cells were harvested 16-20 hours later with a Skatron
Harvester (Skatron Inc., Sterling, VA) onto glass fiber
filters. The filters were allowed to air dry. They were
then placed individually into scintillation vials and
incubated in an oven at 50°C for at least 18 hours.
Radioactivity (measuring T cell proliferation) was
determined in a Beckman LS-5801 liquid scintillation
counter and expressed as counts per minutes (CPM)(See
fig.8).
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Figure 8: Allogeneic mixed lymphocyte respone. Normal
untreated cells as well as BP treated progeny cells were
used as separate responder (R) cell populations (2 X 10'*
cells per well) along with stimulator (S) cells.
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MLR Assay Protocol







BP was injected at a concentration of 150 into
pregnant mice. Mother and progeny were sacrificed at 1
week after birth and the detection of adducts was
performed in thymus.
Experiment 1; This experiment was done to obtain DNA for
conjugation with BPDE according to methodology above.
When conjugation occurs, the conjugate will then be
covalently bound to BSA,„et/ ^ very strong immunogen.
Preliminary studies show conjugation by SFS measurements
(See Fig. 8A).
Experiment 2; The next experiment that was done was to
inject the conjugate into rabbits to produce the antibody.
The rabbit was bled to obtain serum and the antibody
partially purified by EZ-Sep separation and more
specifically, by immunoaffinity chromatography as
described in methodology. Partially purified antibody was
quantitated by ELISA. Affinity purified rabbit anti-BPDE-
DNA is detected by ELISA and used to detect the adduct on
T cell DNA isolated from cells of progeny mice treated
with BP.
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Experiment 3; T-lymphocytes were isolated from BP and
control animals. As described above, the T cells were
first treated with saponin (a mild detergent) to
permeabilize the cell and nuclear membranes. The T-cells
were then stained with propidium iodide, (a DNA dye) ;
followed by immunoaffinity purified rabbit anti-BPDE-DNA,
and then goat anti-rabbit IgG antibody conjugated with
fluorescein isothiocyanate (FITC). The cells were then
subjected to two color flow cytometric analysis, which
would identify the T cells that contain the BPDE-DNA
adduct in the nucleus (i.e., BPDE adduct to DNA).
Experiment 4; Functional characteristics of isolated T-
cells containing BPDE-DNA adducts will be tested by the
MLR. The MLR will be used to test the T-cells ability to
recognize and respond to antigen(s), and their ability to




DNA isolation and conjugation to BPDE
DNA was isolated from mouse progeny (1 week and 6-8
week old according to the Oncor DNA extraction kit as
described in Materials and Methods. The mouse groups used
for DNA isolation were normal (untreated), pregnant
mothers injected with corn oil (CO) and pregnant mothers
injected with benzo (a) pyrene (BP) . The DNA was
quantitated by taking the absorbance at 260^^, multiplied
by the dilution factor, and then multiplied by 50. This
would determine the micrograms per milliliter of DNA. The
amount of DNA used in conjugation and detection
experiments was less than or equal to lOOugml'^ of DNA in
suspension buffer. Also, the A260/A280 ratio was determined
to assure that the DNA was in solution. A DNA ratio of
>1.6 indicates appropriate extraction of the DNA. If the
ratio was less than 1.6, the DNA would have to be re¬
extracted by the same procedures and resuspended.
The average amounts of DNA obtained were as follows:
adult liver approx. 1.2mg
adult spleen approx. 0.75 mg
adult thymus approx. 0.80 mg
fetal liver (6 pups) approx. 1 mg
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After DNA was obtained and quantitated (A260n„/A280nm between
1.8-1.9) , it was conjugated with BPDE in a 1:1 ratio, then
complexed to 1% BSA^gt described in the materials and
methods. Adduct presence was determined by acid
hydrolysis of the adduct and subsequent synchronous
fluorescent spectrophotometry with the emission peak for
the BP tetroal emitted falling at 342^^ (Vahakangas et
al. , 1988) (see fig. 9) . Normal DNA exhibited no emission
peak at 342„^. BPDE alone, when hydrolyzed also did not
exhibit the trademark 342nn, peak. However, BPDE-DNA
(thymus and liver) exhibited an emission peak at 342^^
indicative of the BP tetraol emitted upon successful
hydrolysis of the conjugate BPDE-DNA.
Purification of rabbit antiserum; Once rabbit antiserum
against the conjugate was collected, the antibodies had to
be separated from other serum proteins and macromolecules.
This was accomplished by the EZ-Sep antibody purification
system as described in the methods section. The EZ-Sep
antiserum was then tested for the presence of antibodies
by the ELISA assay. The antigens tested were BPDE, BPDE-
DNA, DNA and BPDE-DNA-BSA. According to the ELISA assay,
the EZ-Sep antiserum reacted against all four antigen
preparations, indicating antibody (titer 1:100) presence
to these antigens (See fig. 10) .
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Figure 9: Synchronous fluorescent spectrophotometric
determination of BPDE-DNA adduct by acid hydrolysis.
Confirmation of in vitro conjugation of BPDE to DNA.
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Figure 10: Results of ELISA assay to test collected
rabbit antiserum for the presence of antibodies against
immunizing antigen(s). Mouse serum and normal rabbit




ELISA Results of EZ-SEP Rabbit a-serum
Mouse Serum Normal Rabbit Rabbit
Serum a-serum
Primary (antibody) protein
Mouse serum was used as a negative control (antigen)
against which the antibodies were tested. The slight
reaction produced by anti-BPDE-DNA-BSA against mouse serum
was probably due to a cross reaction of BSA with mouse
serum albumin. This is evident because there was little
or no reaction between mouse serum and the other rabbit
antibodies present (e.g., rabbit a-BPDE, rabbit o'-BPDE-
DNA, rabbit a-DNA). Normal rabbit serum was also used as
a negative control (antigen), hence a very slight reaction
from rabbit anti-DNA and anti-BPDE-DNA.
The antibody of interest in this case was rabbit ot-
BPDE-DNA, which when isolated, was used to detect the
adduct in T-lymphocyte DNA. In order to obtain the
fraction of serum that contained only rabbit anti-BPDE-
DNA, the serum had to be fractionated further. This was
achieved by the coupling of BPDE to sepharose gel matrix
chromatography column as described in the methods.
Sepharose 6B gel was coupled with BPDE antigen and a
chromatography column prepared. EZ-Sep antiserum samples
were applied to the column and 1ml fractions collected.
Eluants were tested by ELISA for the presence of rabbit
anti- BPDE-DNA at various titers. Anti-BPDE activity was
present up to 1:28 titer and anti-DNA present up to 1:14
titer in the eluants tested. No activity against these
antigens was observed at higher dilutions, while anti-
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BPDE-DNA was identified at a dilution of >1:1000 (See fig.
IIA) . The effluents were also tested and the antibody-
activity against BPDE-DNA, DNA and BPDE of titers from
1:200 (anti-BPDE) , 1:500 (anti-BPDE-DNA) , and 1:80 (anti-
DNA) were tested (See Fig.llB).
Once identified, the fraction of immunoaffinity
purified antibody specific for BPDE-DNA was used to detect
the adduct in DNA isolated from BP and CO treated mice by
ELISA. At primary antibody titer 1:1000, BPDE-DNA adduct
was detected on DNA isolated from 1 week old BP treated
progeny thymus (See fig. 12). No BPDE-DNA adducts were
detected on DNA isolated from 1 week old CO treated
progeny thymus, nor were adducts detected on DNA isolated
from normal (non treated) 1 week old progeny thymus.
However, a strong reaction was observed with DNA in cells
of the progeny recovered from the BP treated pregnant
mother. This indicates the presence of the adduct on the
DNA of these isolated th-ymus cells.
Flow cytometric analysis for detection of adducts in T-
cells; Upon ficoll separation, T-lymphocytes obtained
from the buffy coat layer were aliquoted into 10® cells/ml
aliquots. Ficoll separation is performed in order to
separate the lymphocytes from other cell populations
e.g., red blood cells. The cells were permeabilized with
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Figure 11: Immunoaffinity chromatography result of EZ-Sep
rabbit antiserum. A. Effluents contained antibody
activity against all three antigens tested, titer 1:1000
(BPDE-DNA; BPDE; DNA) . B. Eluants contained high antibody





of EZ-Sep Rabbit Antiserum
Immunoaffinity Chromatography Eluants
of EZ-Sep Rabbit Antiserum
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Figure 12: ELISA results of the detection of BPDE-DNA in





Detection of BPDE-DNA In DNA Isolated
from BP and CO Mouse Progeny by ELISA
saponin, stained with propidium iodide (PI), rabbit anti-
BPDE-DNA and goat anti-rabbit IgG-FITC. The PI stains all
DNA in the cell a red color. The rabbit anti-BPDE-DNA
(primary antibody) stained DNA containing the adduct and
the goat anti-rabbit IgG-FITC would recognize and
fluorescinate (with a green color) the location of the
primary antibody (See fig. 13) .
Upon two color flow cytometric analysis, the cells
containing BPDE-DNA would show up in quadrant 2 (red and
green color). Quadrant one contains cells stained with PI
only (i.e., red color only for DNA). Quadrant three are
negative cells (cells that picked up no fluorescent
antibodies) or PI dye. Quadrant four is the FITC
background staining (green only, i.e. non-specific for
goat Qf-rabbit IgG-FITC) . From the experiments of 1 week
old BP treated progeny thymus, approximately 18% of the
cells assayed were positive for the BPDE-DNA adduct
(quadrant 2 of fig.l4H). CO treated 1 week old progeny
thymus had a background staining of 5%, which was the same
background as the rabbit IgG (negative control--quadrant
2 of fig.l4B&C) . CO and normal 1 week old thymus gave the
same results (See fig.15).
F\inctional assay of BPDE-DNA positive T-cells; In this
experiment, the MLR assay was performed with responder and
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Figure 13: Two color flow cytometry dot plot. Quadrant
1 (red) positive for DNA (propidium iodide stain).
Quadrant 2 (red and green) double positive cells--
positive for BPDE-DNA. Quadrant 3 negative cells (cells
which picked up neither staining antibody). Quadrant 4
(green) positive for FITC (goat anti-rabbit IgG).
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Figure 14 : Two color flow cytometry results of BP and CO
treated 1 week old progeny thymocytes for the detection of
BPDE-DNA. A, CO thy cells only; B, CO thy cells +
saponin + goat anti-rabbit IgG-FITC (2°) ; C, normal thy
cells + PI+ rabbit anti-BPDE-DNA (1°) + 2°; D, BP thy
cells + PI+ rabbit IgG + 2°; E, BP thy cells only; F, BP
thy cells + PI; G, CO thy cells + PI + 1° + 2°; H, BP
thy cells + PI + 1° + 2°. Normal (untreated) and CO 1
week progeny thymocytes used as negative control. Rabbit
IgG as primary antibody used as negative control on BP
treated 1 week progeny thymocytes.
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Figure 15: Composite results of the 2 color flow


























BPDE-DNA Detection in 1 Wk BP Progeny
Thymocytes by Flow Cytometry
B.P. Cells Only
B.P. + Propidium Iodide + Normal Rabbit
Goat Anti-Rabbit-FITC
B.P. + Propidium Iodide + Rabbit Anti-BPDE-DNA
Goat Anti-Rabbit-FITC
stimulator cells. In addition, the cells containing
BPDE-DNA adducts from 1 week old progeny thymus, as
indicated by dual color flow cytometric analysis, were
sorted on the FACSorter. The fraction of cells that were
positive for the BPDE-DNA adduct was added to the
responder cell population (at a concentration of 2 X 10'*
cells per well) Also, the adduct negative population was
also included for the responder cell population in the MLR
assay. The results of these experiments indicate that the
population of cells that contain the BPDE-DNA adduct have
a MLR response that was only 16%(+ 0.02) of the control
(R+S), and the population of cells that did not contain
the adduct had a MLR response that is 22%(+ 0.01) of the
control response (See fig. 16) .
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Figure 16: Results of one way allogeneic mixed lymphocyte
response. Red bar indicates the percent of control
response of BPDE-DNA bearing cells with stimulator cells
(16%) . Blue bar indicates the percent of control response
of BPDE-DNA negative cells with stimulator cells (22%).
**p<0.01
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MLR of 1 Wk BP Progeny Thymocytes
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DISCUSSION
Experiments by Kapitulnik, et al. (1978) were the
first to provide examples of proximate and utlimate
carcinogens for the polycyclic aromatic hydrocarbon BP
carcinogen. The mechanism of activation of the
environmental carcinogen BP has been investigated for many
years. What has not been exhaustively investigated is
BP'S mechanism of immunosuppressive action (Kapitulnik et
al., 1978).
From the results included in this report, it is
evident that DNA isolated from mouse tissues was
successfully conjugated to BPDE. This conjugate alone,
however is not immunogenic enough to elicit an immune
response that would include high levels of antibody
formation. The immunogenicity of a molecule also depends
to a great extent on its degree of foreignness. The
greater the difference between a foreign antigen and an
animal's own antigens, the greater will be the intensity
of the immune response. Immunogenicity also involves the
size of an immunogen--it must be large enough to be
recognized as foreign. Therefore, since DNA is common to
all animals and BPDE is not a large molecule, the
immunogenicity of this conjugate is very low. The
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conjugate then had to be complexed to a stongly
immunogenic carrier molecule, which is usually a
macromolecule to which a hapten may be bound, so making
the hapten immunogenic. A hapten usually is a small
molecule that cannot initiate an immune response unless
first bound to an immunogenic carrier molecule. DNA,
although large, cannot by itself produce an immune
response and therefore can be called a hapten. However,
once a response is initiated, a hapten can react
specifically with its antibody. In this case the hapten
was BPDE-DNA and the carrier molecule was BSA. These
molecules were successfully conjugated as indicated by
confirmation using SFS.
It was necessary to produce antibody against BPDE-DNA
in order to specifically detect the adduct in cells. This
was done by immunizing rabbits for the production of
antibody. Rabbits were used because, unlike mice, they
can generate more antibody in a shorter period of time,
given the differences in body mass and weight.
The immunoaf f inity chromatography procedure described
above utilizing a BPDE epoxy-activated column is a novel
technique in molecular immunology. This procedure has not
been documented to date in the literature. Consequently,
use of this new technique would prove to be extremely
helpful to those who may need to separate specific
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antibodies from polyclonal serum. The development of
immunoaffinity chromatography of anti-BPDE-DNA as
described here should provide a useful tool in the
examination of BPDE-DNA adducts present in biological
systems, including isolated cells. This technique may
also prove useful in the purification of specific antibody
isotypes (e.g., IgG isotype) that may be useful in
subsequent assays for determining what specific pathways
of inhibition by BP may be affected in B-cell
lymphopoiesis and even in T lymphopoiesis (i.e., T helper
1 vs T helper 2).
Once the rabbit anti-BPDE-DNA was obtained, it was
used in ELISA assays to detect the adduct on DNA isolated
from 1 week old progeny thymocytes. DNA isolated from CO
treated progeny and normal (untreated) progeny were used as
negative controls. The specific anti-BPDE-DNA did not
react against CO or normal DNA, because it only recognized
BPDE-DNA at titers >1:28 and not BPDE alone or DNA alone.
Therefore, highly purified antibody against BPDE-DNA
obtained could specifically identify the adduct in vivo
wherever it may be the result of BP metabolism. These
results indicated that there were BPDE-DNA adducts present
1 week postnatal in the thymus of progeny mice from
mothers treated with BP at midgestation.
These experiments reported here describe, for the
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These experiments reported here describe, for the
first time, presence of metabolites of the carcinogen BP
that can adduct to DNA in T lymphocytes that develop in
the thymus. The presence of such potentially mutagenic
adducts may be a precursor event that may lead to
tumorigenic sequence of events.
The next step was to locate the adduct in the nuclei
of T lymphocytes isolated from progeny mice. Saponating
the T cells permeabilized the cell and nuclear membranes,
so that the antibody would have access to the nuclear DNA.
The application of rabbit anti-BPDE-DNA followed by a goat
anti-rabbit IgG-FITC, along with PI afforded the
opportunity to visualize the percentage of cells that
contained the BPDE-DNA adduct on their DNA by flow
cytometric analysis. These results, taken together with
the aforementioned data, provide decisive evidence that
BPDE-DNA adducts are present in 7-day postnatal thymocytes
of progeny animals from mothers exposed to BP at
midgestation. Adducts have also been detected in fetal
liver and thymus (Rodriguez, 1995 unpublished data) by a
^^P labelling procedure. The adducts detected may
originate from one of two places: T-lymphocytes may
directly metabolize BP which results in adduct formation,
or the BPDE metabolite may cross the placenta of the BP-
treated mothers and result in adducts in the progeny.
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Although lymphocytes contain very little AHH,
activity appears after transformation to lymphoblasts in
culture in the presence of a mitogen (i.e., BP) (Busby, et
al. 1972, Whitlock, et al. , 1972). Kouri et al., (1982)
have reported a relatively good correlation between the
basal level of lymphocyte AHH activity and the incidence
of lung cancer in smokers.
These kind of findings are extremely important,
especially when considering T cell ontogeny. If adducts
exist in the prenatal thymus of progeny and persist
postnatally, these adducts may be a key contributor to
developmental aberrations that may occur when the T
lymphocytes are exposed to a mutagen such as BP early in
their ontogenic pathway. These developmental aberrations
may include mutagenic events which may affect the
expression of certain gene products, i.e., cell surface
antigens which can identify specific cells for specific
functions. One can postulate that, depending on where the
metabolite is on the DNA of the T cell (i.e., on the TOR) ,
the ability of the cell to function in recognizing
antigen, particularly deleterious ones, leads to an
anergic situation.
Ultimately, the presence of adducts in the prenatal
thymus may play a role in the obstruction of positive
selection of thymocytes. These positively selected
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thymocytes should enter the circulating population of
thymocytes, however, for reasons of specific recognition
events that may be unfavorable, they may not enter the
population of circulating thymocytes. The adduct's
presence in T lymphocyte ontogeny may allow other T
lymphocytes that come into contact with the adduct
containing cell, to become dysfunctional (i.e., the thymus
cells that do not express the adduct) in the presence of
the BP or BPDE mutagen. As a result of this, once the
adduct (or a consequence of the adduct) is encountered by
a lymphocyte that is providing surveillance of the immune
system, the surveying lymphocyte may already have been
inactivated (anergized) by the effects of the adduct.
Therefore, the adduct persists and cause mutations, which
may ultimately lead to progression of tumorigenesis, as is
often the case observed upon prolonged survival after
treatment with BP and other PAH's (Urso and Gengozian,
1980).
In conclusion, the information provided in this
dissertation clearly documents the presence of BPDE-DNA
adducts in T lymphocytes of progeny animals from mothers
treated with BP at midgestation. The presence of these
adducts has also been shown to have an exacerbating
suppressive action on the ability of these lymphocytes to
elicit a satisfactory cell mediated immune response, as
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measured by the MLR assay. One can now add to the current
body of scientific knowledge a plausible mechanism (See
Fig. 17) for the suppressive action observed as a
of BP treatment, or other chemical carcinogens




Figure 17: Proposed mechanism for the suppressive action
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